Tag: biosimilars

How Generic Drugs Control Healthcare Costs: The Economics of Savings

By : Tamsin Riverton
Date : Jun 19 2026

Discover how generic drugs reduce healthcare spending by 80-85%. Learn about biosimilars, FDA regulations, and the economic impact of generic competition on patient costs.

How Generic Drugs Control Healthcare Costs: A 2026 Guide

By : Tamsin Riverton
Date : Jun 19 2026

Discover how generic drugs cut healthcare costs by 80-85% and dominate 90% of prescriptions. Learn about biosimilars, patent barriers, and real-world savings in this 2026 guide.

Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now

By : Tamsin Riverton
Date : Feb 2 2026

Patent expiry means cheaper drugs-but only if you plan ahead. Learn what patients and healthcare systems must do now to avoid disruptions and save money when brand-name medications lose exclusivity.

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

By : Tamsin Riverton
Date : Dec 24 2025

The FDA's Purple Book is the official database for biosimilars and interchangeable biological products. Learn how it works, which products are substitutable, and why state laws still control pharmacy substitutions.